objectives To determine the prevalence and predictors of gestational diabetes mellitus (GDM) as well as acceptability of returning for glucose tolerance testing among pregnant women in Moshi municipality, northern Tanzania.
Introduction
Gestational diabetes mellitus (GDM), as defined by WHO, 'is any degree of glucose intolerance with onset or first recognised during pregnancy' [1] . The definition of GDM has evolved, and currently WHO recommends that hyperglycaemia first detected anytime during pregnancy should be further subdivided into either diabetes mellitus in pregnancy (DIP) or GDM. A pregnant woman whose hyperglycaemia is first detected during pregnancy meets the WHO criteria of diagnosis of diabetes in non-pregnant status; she then has DIP [1, 2] . DIP may be pre-existing diabetes before pregnancy or diabetes that is first diagnosed during pregnancy. GDM on the other hand includes pregnant women who meet the WHO criteria for diagnosis of impaired glucose tolerance but not DIP [1, 2] . GDM is prevalent, and the International Diabetes Federation (IDF) estimates that 17% of the global live births are from women with some form of hyperglycaemia, 84% due to GDM [3] . Macaulay et al. (2014) [4] reported that GDM affects 5.9%-13.9% of pregnant women in low-and middle-income countries. The few studies that have been published in Sub-Saharan Africa reported GDM prevalence ranging from 0% to 3.9% between 1991 and 1999, increasing to 5-9% in studies conducted between 2000 and 2013. However, different diagnostic criteria were used to diagnose GDM in that period [4] [5] [6] [7] [8] [9] [10] .
GDM is associated with a higher risk of negative pregnancy outcomes. These include the following: higher risk of obstructed labour due to large babies, higher rates of Caesarean section, birth trauma, risk of postpartum haemorrhage, hypertensive disorders of pregnancy and increased risk of developing diabetes and cardiovascular diseases in the future [11] [12] [13] [14] . Perinatal complications include the following: macrosomia, birth trauma due to shoulder dystocia, neonatal hypoglycaemia, hyperbilirubinemia and increased risk of perinatal death [2, [15] [16] [17] . In utero imprinting increases the risk of children born to mothers with GDM to develop obesity, overt diabetes and cardio-metabolic disorders as long-term complications [2, [15] [16] [17] .
Routine screening for hyperglycaemia in pregnancy is not carried out in most low-and middle-income countries (LMICs) including Tanzania, despite the known negative outcomes of GDM and future link to non-communicable diseases (NCDs). LMICs suffer 80% of the global burden of diabetes and 90% of maternal and perinatal mortality [2, 3, 18] . Part of the problem was lack of consensus regarding screening and diagnosis of gestational diabetes and the presence of different diagnostic criteria [1, 19] . Currently, FIGO is recommending that researchers should use the new WHO (2013) diagnostic criteria in screening for GDM [2] .
In Tanzania, there is a lack of information on the burden and predictors of GDM. A study by Mwanri et al. (2013) [10] using the WHO 1999 criteria showed that 8.4% of pregnant women have GDM in Dar es Salaam. Our study was performed in north-eastern Tanzania to describe the uptake, prevalence and factors associated with GDM, using the WHO 2013 criteria.
Methods and patients
From October 2015 to April 2016, we conducted a cross-sectional study at three facilities: KCMC referral hospital, Majengo Health Centre and Pasua Health Centre in Moshi municipality. Moshi municipality is one of the seven districts of Kilimanjaro region. It has a population of 184 292 according to the 2012 census with approximately 11 600 deliveries per year. Of these, 41% take place at KCMC hospital, 11% at Majengo HC and 7% at Pasua HC (Moshi Municipal Annual Report of 2015); thus, the selected facilities provide antenatal and delivery care to approximately 60% of the pregnant women in Moshi municipality.
All pregnant women attending for routine antenatal care at the three facilities during the study period with a gestational age of 24-28 weeks were eligible to participate. Before enrolment, women were informed about the study and its aims, about hyperglycaemia in pregnancy and its effects and on the importance of screening. Consenting women were first interviewed by trained research nurses to collect information on socio-demographic characteristics and other key predictors for GDM. After the interviews, blood pressure and anthropometric measurements were taken (weight in kilograms, height in centimetres and mid-arm upper circumference (MUAC) in cm). Two readings were taken for each measure. A SECA scale, a stadiometer and UNICEF MUAC tapes were used for the anthropometric measurements. A BP machine (Manual/Riester) was used to measure blood pressure.
The women were requested to return the next day or within a month, depending on gestational age (in weeks), for fasting plasma glucose (FPG) and oral glucose tolerance (OGTT) testing. They were requested to fast for at least 8 h the night before they came for the appointment. Fasting plasma glucose testing was performed immediately after arrival. Depending on the results, this was followed by a 75 g, 2-h oral glucose tolerance test (OGTT). Women who had FPG of ≥7.0 mmol/l did not take the OGTT test, as an FPG >7.0 mmol/l alone indicates diabetes in pregnancy (DIP). Plasma-calibrated hand-held glucometers (GlucoPlus) were used to measure FPG and 2-h glucose level.
GDM diagnosis was made using the 2013 WHO criteria [1] . Diabetes in pregnancy (DIP) was diagnosed if FPG was ≥7.0 mmol/l or the 2-h plasma glucose was ≥11.1 mmol/l. GDM was diagnosed if FPG was 5.1-6.9 mmol/l or 2-h plasma glucose was 8.5-11.0 mmol/l.
An MUAC of ≥28 cm was taken to indicate pre-gestational overweight and/or obesity. According to Khadivzadeh (2002) , MUAC is relatively stable during pregnancy with an almost negligible increase of 0.05 cm through the course of pregnancy [20] . High blood pressure was diagnosed in cases of systolic BP ≥140 mmHg and diastolic BP ≥90 mmHg 1].
Pregnant women with DIP were immediately referred for specialised care at KCMC referral hospital. Women with GDM who were enrolled at KCMC were all seen by specialists (as all the complicated cases are seen by specialists). Women at the two primary healthcare clinics with GDM were given nutritional counselling and recommended to start physical activity of moderate to intensive level for at least 30 minutes daily. They were requested to return weekly for FPG measures. If FPG control at the second week was still high (FPG >5.3 mmol/l), they were also referred for specialised care at KCMC hospital. The importance of continuing regular blood monitoring, nutrition and physical activity even after delivery was pointed out to the women with GDM.
Data were entered and analysed using the Statistical Package for Social Sciences (SPSS) version 22.0 (IBM, NY, USA). Descriptive statistics were used to summarise data, where continuous variables were summarised using mean or median with their respective measure of spread and categorical variables were summarised using percentages. The strength of association between GDM and several factors was assessed using odds ratios (OR) and with their 95% confidence interval (CI). Logistic regression analysis was conducted to control for confounders. A Pvalue of <5% was taken as statistically significant results.
Ethical approval was obtained from the KCMU College Research and Ethics Committee (Ethical clearance no 864). Written informed consent was sought from each study participant. To maintain confidentiality, only numbers were used in all the questionnaires and laboratory forms. The women did not have to pay for FPG and OGTT tests. The project covered the cost.
Results
Of the 433 interviewed women, 333 (77%) returned for fasting plasma glucose and OGTT testing. The characteristics of pregnant women who did not return for FPG testing did not differ in terms of age, education or income from those who returned (Table 1) . However, pregnant women who were single, separated or divorced (not in union), had twice the odds of not returning for FBG testing than those who were married or cohabiting (OR 2.61: 95% CI: 1.47-4.63).
Mean age of the 333 screened women was 27.9 years (SD 5.9). Most were married/cohabiting (89.5%), not formally employed (71%) and had primary education (52.3%, Table 2 ). The median number of previous pregnancies was 2 (IQR 1-3); 85% had ≤ 2 children (85%). A history of delivery of a baby weighing ≥4 kgwas reported by 17%. Table 3 depicts some factors that may increase the odds of hyperglycaemia during pregnancy. A family history of diabetes mellitus was reported by 9%, and 6% had high blood pressure on the day of testing. The recommended moderate to vigorous intensity exercise for more than 150 minutes per week was reported by only 7% of the women; 44% had a mid-upper arm circumference (MUAC) of ≥28 cm signifying pre-pregnancy overweight and/or obesity (Table 3) . Alcohol intake was reported by 13% and smoking by 0.6%.
Knowledge of one's pre-pregnancy weight was reported by 179 (53%) of the 333 women. Of these, 35.4% (64) had a normal BMI (18.5-24.9) while 33.1% (59) were overweight and 29.2% (52) were obese.
Three per cent (n = 11) of the 333 pregnant women had diabetes in pregnancy (DIP). The prevalence of GDM was 19.5% (Table 4) . In the bivariate analysis, GDM was significantly associated with age ≥35 years, gravida ≥3, mid-arm upper circumference ≥28 cm and pre-pregnancy obesity (BMI of 30 or more, Table 5 ). Other factors, such as education, income, history of delivery of a large baby, history of intrauterine foetal death, family history of diabetes and diagnosis of hypertension during current pregnancy, were analysed but were not associated with GDM. In the logistic regression analysis, GDM was independently associated with MUAC of ≥28 OGTT, oral glucose tolerance test. *n = 327: minus 6 women with FPG >7.0 mmol/l. OR, odds ratio; CI, confidence interval. Adjusted for age, gravida, history of abortion, family history of diabetes, hypertensive disorder of pregnancy, history of abortion, history of delivery of baby ≥ 4 kg, and MUAC. *Represent pre-pregnancy overweight/obesity.
Discussion
The prevalence of GDM found in this setting was high. One in five (1/5) pregnant women had glucose intolerance according to 2013 WHO criteria. This result is consistent with the projected prevalence of GDM (18%) for all pregnant women if diagnosis is based on these criteria [1] . The results are much higher than the observed GDM prevalence of 8.4% among pregnant women in Dar es Salaam [10] , and a prevalence of 8.3% in Nigeria and 8.8% in South Africa [7] [8] [9] . Previous studies used the 1999 WHO criteria for diagnosis of GDM. The prevalence of GDM observed in Moshi might be higher because cut-off points for FBG and OGTT in the new WHO criteria of 2013 are lower than those in previous guidelines [1, 2] . Given the high prevalence of GDM in this setting with its known short-and long-term consequences, there is an urgent need to start routine screening during pregnancy using a one-step approach [2] . Management and followup guidelines for women with GDM and DIP during and after pregnancy need to be developed in Tanzania taking into account the availability of resources and trained personnel.
One of the key challenges observed in GDM screening was the loss of 23% of the pregnant women who did not return for FBG and OGTT testing, a high proportion given the high prevalence of GDM detected. These results are similar to the observations in Dar es Salaam by Mwanri and colleagues [10] . Using the testing strategy as used in India of performing a single-step, 75-g 2-h glucose tolerance test without considering fasting state may be one of the strategies to reduce the loss to testing that was noted in 23% of the women [2] .
Personal income may be a barrier to return for FBG and OGTT testing in our setting. Women who were not in union (single, divorced, separated) were less likely to return for GDM screening than women who were in union. Cost has been shown to be one of the barriers for health care seeking for several maternal and newborn health services in Tanzania [22] . We speculate that women who were not in union could not afford an extra visit to the clinic due to costs (fare and hospital fee), in contrast to women who might receive support from their partners once they are able to explain the importance of testing. Matching FBG and OGTT testing with scheduled clinic visits may reduce the failure to return for screening in Moshi.
The issue of the acceptability of testing may have affected the return of some women. FPG testing and OGTT testing were a new experience for them, because they are not part of routine investigations offered during pregnancy. Returning to the clinics in a fasting state, undertaking OGTT, waiting for 2 h and being pricked twice for blood testing may be difficult for some. Although they accepted being interviewed, they may have had issues with the acceptability of new tests. Therefore, if screening for GDM is to be part of routine ANC care in Tanzania, formative research will be needed to understand how women perceive, understand and accept the tests and to address emerging problems early to achieve universal testing.
A mid-upper arm circumference of ≥28 cm, signifying pre-pregnancy overweight and/or obesity, was associated with increased odds of having GDM. Khadivzadeh ) in China also reported that a BMI of ≥30 kg/m 2 was associated with GDM [7, 10, 20, 21] . In general, the prevalence of overweight and obesity among women of reproductive age is higher in Kilimanjaro region (35%) than the national prevalence of 22% [22] . Interventions to improve physical activity and dietary habits towards a healthy weight among women of reproductive age in general are needed in this setting. Optimally, women should enter pregnancy with an appropriate weight.
A history of abortion was associated with GDM in this setting. It is postulated that the presence of hyperglycaemia during organogenesis increases the risk of spontaneous abortion and DIP may increase the risk of congenital malformation [2] . Plasma glucose is not among the battery of investigations that is undertaken in women with a history of abortion in Tanzania and clinicians need to think beyond the traditional causes when investigating women for abortion.
The use of point of care tests may have influenced the results because several studies have shown that glucometer results are less accurate and precise than those from quality-controlled laboratories that use serum or plasma for measurement [2, 23] . WHO however recommends that in the settings where laboratories or proper storage and transport of blood samples is not assured, which was the case in our setting, plasma-calibrated hand-held glucometers can be used because of convenience and an acceptable reliability [2] . Further, due to financial and logistic limitations, we did not validate the FPG results from glucometers with laboratory-based testing. Future studies will need to take this into account. Another limitation of the study is lack of follow-up to delivery and beyond pregnancy. The need to follow-up women with GDM and DIP beyond pregnancy is important in order to manage those with persistent raised blood glucose and link others to long-term follow-up because they are at increased risk to develop diabetes.
Conclusions
It is concluded that GDM is a problem among pregnant women in Moshi municipality. Routine screening is recommended so that timely preventive and curative care can be offered to avoid negative pregnancy outcomes. National and facility guidelines for testing, management and follow-up for GDM need to be developed. Further, information and education targeting women of reproductive age on the effects of overweight/obesity are needed along with other general interventions to address the obesity problem.
